Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Xtant Medical Holdings (XTNT) Long-Term Debt Repayments (2016 - 2021)

Xtant Medical Holdings has reported Long-Term Debt Repayments over the past 12 years, most recently at -$73000.0 for Q3 2021.

  • Quarterly Long-Term Debt Repayments fell 282.5% to -$73000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $411000.0 through Dec 2021, up 30.48% year-over-year, with the annual reading at $411000.0 for FY2021, 30.48% up from the prior year.
  • Long-Term Debt Repayments was -$73000.0 for Q3 2021 at Xtant Medical Holdings, down from $176000.0 in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $308000.0 in Q1 2021 and troughed at -$115000.0 in Q4 2017.
  • The 5-year median for Long-Term Debt Repayments is $88000.0 (2018), against an average of $85684.2.
  • The largest YoY upside for Long-Term Debt Repayments was 805.88% in 2021 against a maximum downside of 282.5% in 2021.
  • A 5-year view of Long-Term Debt Repayments shows it stood at -$115000.0 in 2017, then soared by 186.09% to $99000.0 in 2018, then plummeted by 39.39% to $60000.0 in 2019, then surged by 233.33% to $200000.0 in 2020, then crashed by 136.5% to -$73000.0 in 2021.
  • Per Business Quant, the three most recent readings for XTNT's Long-Term Debt Repayments are -$73000.0 (Q3 2021), $176000.0 (Q2 2021), and $308000.0 (Q1 2021).